these other items referred to in the announcement were not new but in their plans at the AGM. It's my view they are considering the capital return implications for something else now in the pipeline. I'd be surprised if it the return was not now cancelled in two months-time, or deferred indefinitely like that nuvaring launch
Ann: Mayne Pharma provides update on capital management timeline, page-5
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.50 |
Change
-0.120(2.60%) |
Mkt cap ! $382.8M | |||
| Open | High | Low | Value | Volume |
| $4.60 | $4.62 | $4.47 | $280.2K | 61.90K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 126 | $4.50 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.52 | 538 | 1 |
View Market Depth
| Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
| MYX (ASX) Chart |